Carbon-based biosensors from graphene family to carbon dots: A viewpoint in cancer detection

According to the latest report by International Agency for Research on Cancer, 19.3 million new cancer cases and 10 million cancer deaths were globally reported in 2020. Early diagnosis can reduce these numbers significantly, and biosensors have appeared to be a solution to this problem as, unlike t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Talanta (Oxford) 2023-06, Vol.258, p.124399-124399, Article 124399
Hauptverfasser: Safari, Mohammad, Moghaddam, Armaghan, Salehi Moghaddam, Abolfazl, Absalan, Moloud, Kruppke, Benjamin, Ruckdäschel, Holger, Khonakdar, Hossein Ali
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 124399
container_issue
container_start_page 124399
container_title Talanta (Oxford)
container_volume 258
creator Safari, Mohammad
Moghaddam, Armaghan
Salehi Moghaddam, Abolfazl
Absalan, Moloud
Kruppke, Benjamin
Ruckdäschel, Holger
Khonakdar, Hossein Ali
description According to the latest report by International Agency for Research on Cancer, 19.3 million new cancer cases and 10 million cancer deaths were globally reported in 2020. Early diagnosis can reduce these numbers significantly, and biosensors have appeared to be a solution to this problem as, unlike the traditional methods, they have low cost, rapid process, and do not need experts present on site for use. These devices have been incorporated to detect many cancer biomarkers and measure cancer drug delivery. To design these biosensors, a researcher must know about their different types, properties of nanomaterials, and cancer biomarkers. Among all types of biosensors, electrochemical and optical biosensors are the most sensitive and promising sensors for detecting complicated diseases like cancer. The carbon-based nanomaterial family has attracted lots of attention due to their low cost, easy preparation, biocompatibility, and significant electrochemical and optical properties. In this review, we have discussed the application of graphene and its derivatives, carbon nanotubes (CNTs), carbon dots (CDs), and fullerene (C60), for designing different electrochemical and optical cancer-detecting biosensors. Furthermore, the application of these carbon-based biosensors for detecting seven widely studied cancer biomarkers (HER2, CEA, CA125, VEGF, PSA, Alpha-fetoprotein, and miRNA21) is reviewed. Finally, various fabricated carbon-based biosensors for detecting cancer biomarkers and anticancer drugs are comprehensively summarized as well. [Display omitted] •While millions of cancer diagnosis and deaths are reported annually, early diagnosis can reduce these numbers significantly.•Biosensors can be used for early diagnosis and do not require expert staff on site.•The carbon-based nanomaterials can be used as biosensors with high precision rates.•Carbon-based biosensors can now be used for detecting seven widely studied cancer biomarkers.
doi_str_mv 10.1016/j.talanta.2023.124399
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3153784093</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0039914023001509</els_id><sourcerecordid>3153784093</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-dc5f463b6ca09f8debd986b0f6167f581969ea716e31d0d717ca35b0db1758473</originalsourceid><addsrcrecordid>eNqFkU1vEzEQhi1E1aalPwHkI5cN9s6uP7igKoKCVKkXuCFZ_pgFR9l1sB2q_ntcErj2NId5ZkbzvIS85mzNGRfvtutqd3apdt2zHta8H0DrF2TFlYQORgkvyYox0J3mA7sgl6VsGWskg3NyAUJJxkdYke8bm11aOmcLBupiKriUlAudcprpj2z3P3FBOtk57h5pTdT_5WlItbynN_R3xId9ikulcWm9xWOmASv6GtPyipxNdlfw-lSvyLdPH79uPnd397dfNjd3nQetahf8OA0CnPCW6UkFdEEr4dgkuJDTqLgWGq3kAoEHFiSX3sLoWHBcjmqQcEXeHvfuc_p1wFLNHIvHXfOD6VAMtFelGpiGZ9FeKhi0kLxv6HhEfU6lZJzMPsfZ5kfDmXnKwGzNKQPzlIE5ZtDm3pxOHNyM4f_UP-kN-HAEsDlpArMpPmJTF2Ju4kxI8ZkTfwCAq5pa</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2783496712</pqid></control><display><type>article</type><title>Carbon-based biosensors from graphene family to carbon dots: A viewpoint in cancer detection</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Safari, Mohammad ; Moghaddam, Armaghan ; Salehi Moghaddam, Abolfazl ; Absalan, Moloud ; Kruppke, Benjamin ; Ruckdäschel, Holger ; Khonakdar, Hossein Ali</creator><creatorcontrib>Safari, Mohammad ; Moghaddam, Armaghan ; Salehi Moghaddam, Abolfazl ; Absalan, Moloud ; Kruppke, Benjamin ; Ruckdäschel, Holger ; Khonakdar, Hossein Ali</creatorcontrib><description>According to the latest report by International Agency for Research on Cancer, 19.3 million new cancer cases and 10 million cancer deaths were globally reported in 2020. Early diagnosis can reduce these numbers significantly, and biosensors have appeared to be a solution to this problem as, unlike the traditional methods, they have low cost, rapid process, and do not need experts present on site for use. These devices have been incorporated to detect many cancer biomarkers and measure cancer drug delivery. To design these biosensors, a researcher must know about their different types, properties of nanomaterials, and cancer biomarkers. Among all types of biosensors, electrochemical and optical biosensors are the most sensitive and promising sensors for detecting complicated diseases like cancer. The carbon-based nanomaterial family has attracted lots of attention due to their low cost, easy preparation, biocompatibility, and significant electrochemical and optical properties. In this review, we have discussed the application of graphene and its derivatives, carbon nanotubes (CNTs), carbon dots (CDs), and fullerene (C60), for designing different electrochemical and optical cancer-detecting biosensors. Furthermore, the application of these carbon-based biosensors for detecting seven widely studied cancer biomarkers (HER2, CEA, CA125, VEGF, PSA, Alpha-fetoprotein, and miRNA21) is reviewed. Finally, various fabricated carbon-based biosensors for detecting cancer biomarkers and anticancer drugs are comprehensively summarized as well. [Display omitted] •While millions of cancer diagnosis and deaths are reported annually, early diagnosis can reduce these numbers significantly.•Biosensors can be used for early diagnosis and do not require expert staff on site.•The carbon-based nanomaterials can be used as biosensors with high precision rates.•Carbon-based biosensors can now be used for detecting seven widely studied cancer biomarkers.</description><identifier>ISSN: 0039-9140</identifier><identifier>EISSN: 1873-3573</identifier><identifier>DOI: 10.1016/j.talanta.2023.124399</identifier><identifier>PMID: 36870153</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Anticancer drugs ; antineoplastic agents ; biocompatibility ; biomarkers ; Biomarkers, Tumor ; Biosensing Techniques - methods ; Biosensors ; Cancer biomarkers ; Cancer diagnosis ; Carbon nanomaterials ; carbon nanotubes ; early diagnosis ; Electrochemical Techniques - methods ; electrochemistry ; family ; fullerene ; graphene ; Graphite - chemistry ; Nanostructures - chemistry ; Nanotubes, Carbon - chemistry ; Neoplasms - diagnosis ; researchers</subject><ispartof>Talanta (Oxford), 2023-06, Vol.258, p.124399-124399, Article 124399</ispartof><rights>2023</rights><rights>Copyright © 2023. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c398t-dc5f463b6ca09f8debd986b0f6167f581969ea716e31d0d717ca35b0db1758473</citedby><cites>FETCH-LOGICAL-c398t-dc5f463b6ca09f8debd986b0f6167f581969ea716e31d0d717ca35b0db1758473</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.talanta.2023.124399$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27911,27912,45982</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36870153$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Safari, Mohammad</creatorcontrib><creatorcontrib>Moghaddam, Armaghan</creatorcontrib><creatorcontrib>Salehi Moghaddam, Abolfazl</creatorcontrib><creatorcontrib>Absalan, Moloud</creatorcontrib><creatorcontrib>Kruppke, Benjamin</creatorcontrib><creatorcontrib>Ruckdäschel, Holger</creatorcontrib><creatorcontrib>Khonakdar, Hossein Ali</creatorcontrib><title>Carbon-based biosensors from graphene family to carbon dots: A viewpoint in cancer detection</title><title>Talanta (Oxford)</title><addtitle>Talanta</addtitle><description>According to the latest report by International Agency for Research on Cancer, 19.3 million new cancer cases and 10 million cancer deaths were globally reported in 2020. Early diagnosis can reduce these numbers significantly, and biosensors have appeared to be a solution to this problem as, unlike the traditional methods, they have low cost, rapid process, and do not need experts present on site for use. These devices have been incorporated to detect many cancer biomarkers and measure cancer drug delivery. To design these biosensors, a researcher must know about their different types, properties of nanomaterials, and cancer biomarkers. Among all types of biosensors, electrochemical and optical biosensors are the most sensitive and promising sensors for detecting complicated diseases like cancer. The carbon-based nanomaterial family has attracted lots of attention due to their low cost, easy preparation, biocompatibility, and significant electrochemical and optical properties. In this review, we have discussed the application of graphene and its derivatives, carbon nanotubes (CNTs), carbon dots (CDs), and fullerene (C60), for designing different electrochemical and optical cancer-detecting biosensors. Furthermore, the application of these carbon-based biosensors for detecting seven widely studied cancer biomarkers (HER2, CEA, CA125, VEGF, PSA, Alpha-fetoprotein, and miRNA21) is reviewed. Finally, various fabricated carbon-based biosensors for detecting cancer biomarkers and anticancer drugs are comprehensively summarized as well. [Display omitted] •While millions of cancer diagnosis and deaths are reported annually, early diagnosis can reduce these numbers significantly.•Biosensors can be used for early diagnosis and do not require expert staff on site.•The carbon-based nanomaterials can be used as biosensors with high precision rates.•Carbon-based biosensors can now be used for detecting seven widely studied cancer biomarkers.</description><subject>Anticancer drugs</subject><subject>antineoplastic agents</subject><subject>biocompatibility</subject><subject>biomarkers</subject><subject>Biomarkers, Tumor</subject><subject>Biosensing Techniques - methods</subject><subject>Biosensors</subject><subject>Cancer biomarkers</subject><subject>Cancer diagnosis</subject><subject>Carbon nanomaterials</subject><subject>carbon nanotubes</subject><subject>early diagnosis</subject><subject>Electrochemical Techniques - methods</subject><subject>electrochemistry</subject><subject>family</subject><subject>fullerene</subject><subject>graphene</subject><subject>Graphite - chemistry</subject><subject>Nanostructures - chemistry</subject><subject>Nanotubes, Carbon - chemistry</subject><subject>Neoplasms - diagnosis</subject><subject>researchers</subject><issn>0039-9140</issn><issn>1873-3573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1vEzEQhi1E1aalPwHkI5cN9s6uP7igKoKCVKkXuCFZ_pgFR9l1sB2q_ntcErj2NId5ZkbzvIS85mzNGRfvtutqd3apdt2zHta8H0DrF2TFlYQORgkvyYox0J3mA7sgl6VsGWskg3NyAUJJxkdYke8bm11aOmcLBupiKriUlAudcprpj2z3P3FBOtk57h5pTdT_5WlItbynN_R3xId9ikulcWm9xWOmASv6GtPyipxNdlfw-lSvyLdPH79uPnd397dfNjd3nQetahf8OA0CnPCW6UkFdEEr4dgkuJDTqLgWGq3kAoEHFiSX3sLoWHBcjmqQcEXeHvfuc_p1wFLNHIvHXfOD6VAMtFelGpiGZ9FeKhi0kLxv6HhEfU6lZJzMPsfZ5kfDmXnKwGzNKQPzlIE5ZtDm3pxOHNyM4f_UP-kN-HAEsDlpArMpPmJTF2Ju4kxI8ZkTfwCAq5pa</recordid><startdate>20230601</startdate><enddate>20230601</enddate><creator>Safari, Mohammad</creator><creator>Moghaddam, Armaghan</creator><creator>Salehi Moghaddam, Abolfazl</creator><creator>Absalan, Moloud</creator><creator>Kruppke, Benjamin</creator><creator>Ruckdäschel, Holger</creator><creator>Khonakdar, Hossein Ali</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope></search><sort><creationdate>20230601</creationdate><title>Carbon-based biosensors from graphene family to carbon dots: A viewpoint in cancer detection</title><author>Safari, Mohammad ; Moghaddam, Armaghan ; Salehi Moghaddam, Abolfazl ; Absalan, Moloud ; Kruppke, Benjamin ; Ruckdäschel, Holger ; Khonakdar, Hossein Ali</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-dc5f463b6ca09f8debd986b0f6167f581969ea716e31d0d717ca35b0db1758473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Anticancer drugs</topic><topic>antineoplastic agents</topic><topic>biocompatibility</topic><topic>biomarkers</topic><topic>Biomarkers, Tumor</topic><topic>Biosensing Techniques - methods</topic><topic>Biosensors</topic><topic>Cancer biomarkers</topic><topic>Cancer diagnosis</topic><topic>Carbon nanomaterials</topic><topic>carbon nanotubes</topic><topic>early diagnosis</topic><topic>Electrochemical Techniques - methods</topic><topic>electrochemistry</topic><topic>family</topic><topic>fullerene</topic><topic>graphene</topic><topic>Graphite - chemistry</topic><topic>Nanostructures - chemistry</topic><topic>Nanotubes, Carbon - chemistry</topic><topic>Neoplasms - diagnosis</topic><topic>researchers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Safari, Mohammad</creatorcontrib><creatorcontrib>Moghaddam, Armaghan</creatorcontrib><creatorcontrib>Salehi Moghaddam, Abolfazl</creatorcontrib><creatorcontrib>Absalan, Moloud</creatorcontrib><creatorcontrib>Kruppke, Benjamin</creatorcontrib><creatorcontrib>Ruckdäschel, Holger</creatorcontrib><creatorcontrib>Khonakdar, Hossein Ali</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Talanta (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Safari, Mohammad</au><au>Moghaddam, Armaghan</au><au>Salehi Moghaddam, Abolfazl</au><au>Absalan, Moloud</au><au>Kruppke, Benjamin</au><au>Ruckdäschel, Holger</au><au>Khonakdar, Hossein Ali</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carbon-based biosensors from graphene family to carbon dots: A viewpoint in cancer detection</atitle><jtitle>Talanta (Oxford)</jtitle><addtitle>Talanta</addtitle><date>2023-06-01</date><risdate>2023</risdate><volume>258</volume><spage>124399</spage><epage>124399</epage><pages>124399-124399</pages><artnum>124399</artnum><issn>0039-9140</issn><eissn>1873-3573</eissn><abstract>According to the latest report by International Agency for Research on Cancer, 19.3 million new cancer cases and 10 million cancer deaths were globally reported in 2020. Early diagnosis can reduce these numbers significantly, and biosensors have appeared to be a solution to this problem as, unlike the traditional methods, they have low cost, rapid process, and do not need experts present on site for use. These devices have been incorporated to detect many cancer biomarkers and measure cancer drug delivery. To design these biosensors, a researcher must know about their different types, properties of nanomaterials, and cancer biomarkers. Among all types of biosensors, electrochemical and optical biosensors are the most sensitive and promising sensors for detecting complicated diseases like cancer. The carbon-based nanomaterial family has attracted lots of attention due to their low cost, easy preparation, biocompatibility, and significant electrochemical and optical properties. In this review, we have discussed the application of graphene and its derivatives, carbon nanotubes (CNTs), carbon dots (CDs), and fullerene (C60), for designing different electrochemical and optical cancer-detecting biosensors. Furthermore, the application of these carbon-based biosensors for detecting seven widely studied cancer biomarkers (HER2, CEA, CA125, VEGF, PSA, Alpha-fetoprotein, and miRNA21) is reviewed. Finally, various fabricated carbon-based biosensors for detecting cancer biomarkers and anticancer drugs are comprehensively summarized as well. [Display omitted] •While millions of cancer diagnosis and deaths are reported annually, early diagnosis can reduce these numbers significantly.•Biosensors can be used for early diagnosis and do not require expert staff on site.•The carbon-based nanomaterials can be used as biosensors with high precision rates.•Carbon-based biosensors can now be used for detecting seven widely studied cancer biomarkers.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>36870153</pmid><doi>10.1016/j.talanta.2023.124399</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0039-9140
ispartof Talanta (Oxford), 2023-06, Vol.258, p.124399-124399, Article 124399
issn 0039-9140
1873-3573
language eng
recordid cdi_proquest_miscellaneous_3153784093
source Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE
subjects Anticancer drugs
antineoplastic agents
biocompatibility
biomarkers
Biomarkers, Tumor
Biosensing Techniques - methods
Biosensors
Cancer biomarkers
Cancer diagnosis
Carbon nanomaterials
carbon nanotubes
early diagnosis
Electrochemical Techniques - methods
electrochemistry
family
fullerene
graphene
Graphite - chemistry
Nanostructures - chemistry
Nanotubes, Carbon - chemistry
Neoplasms - diagnosis
researchers
title Carbon-based biosensors from graphene family to carbon dots: A viewpoint in cancer detection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T04%3A04%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carbon-based%20biosensors%20from%20graphene%20family%20to%20carbon%20dots:%20A%20viewpoint%20in%20cancer%20detection&rft.jtitle=Talanta%20(Oxford)&rft.au=Safari,%20Mohammad&rft.date=2023-06-01&rft.volume=258&rft.spage=124399&rft.epage=124399&rft.pages=124399-124399&rft.artnum=124399&rft.issn=0039-9140&rft.eissn=1873-3573&rft_id=info:doi/10.1016/j.talanta.2023.124399&rft_dat=%3Cproquest_cross%3E3153784093%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2783496712&rft_id=info:pmid/36870153&rft_els_id=S0039914023001509&rfr_iscdi=true